Literature DB >> 26313377

Pirinixic acids: flexible fatty acid mimetics with various biological activities.

Daniel Merk1, Martina Zettl1, Dieter Steinhilber1, Oliver Werz2, Manfred Schubert-Zsilavecz1.   

Abstract

Pirinixic acid is a typical fatty acid mimetic and was developed as synthetic antihyperlipidemic agent. While its target remained unknown in the early development, it has later been characterized as dual PPARα/γ agonist. Based on this activity, pirinixic acid has served as a lead compound for several structure-activity relationship (SAR) studies addressing diverse targets for lipid mimetics. Many structural variants of pirinixic acid descendants have been developed and thereby potent agents on metabolic, inflammatory and neuroprotective targets were discovered of which some have proven in vivo efficacy. This article reviews pirinixic acid descendants along with their in vitro-pharmacological profiles, summarizes their in vivo data and finally gives a future perspective for this valuable class of fatty acid mimetics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26313377     DOI: 10.4155/fmc.15.87

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  2 in total

1.  Hepatoprotective role of peroxisome proliferator-activated receptor-α in non-cancerous hepatic tissues following transcatheter arterial embolization.

Authors:  Peiyu Yang; Zhengliang Li; Wei Du; Chunhua Wu; Wencui Xiong
Journal:  Open Life Sci       Date:  2022-08-11       Impact factor: 1.311

2.  Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro.

Authors:  Pascal Heitel; Leonie Gellrich; Jan Heering; Tamara Goebel; Astrid Kahnt; Ewgenij Proschak; Manfred Schubert-Zsilavecz; Daniel Merk
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.